sodium salicylate has been researched along with pioglitazone in 1 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (pioglitazone) | Trials (pioglitazone) | Recent Studies (post-2010) (pioglitazone) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,338 | 824 | 2,277 |
Protein | Taxonomy | sodium salicylate (IC50) | pioglitazone (IC50) |
---|---|---|---|
CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 2 | |
Peroxisome proliferator-activated receptor gamma | Rattus norvegicus (Norway rat) | 0.7 | |
Bile salt export pump | Homo sapiens (human) | 0.337 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.114 | |
Steryl-sulfatase | Homo sapiens (human) | 0.8 | |
Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 1.15 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.298 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.0379 | |
Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | 0.7 | |
CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 4.8 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 8.65 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berney, T; Bosco, D; Donath, MY; Halban, PA; Maedler, K; Zeender, E | 1 |
1 other study(ies) available for sodium salicylate and pioglitazone
Article | Year |
---|---|
Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cells, Cultured; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Interleukin-1; Islets of Langerhans; NF-kappa B; Nitric Oxide; Pioglitazone; Sodium Salicylate; Thiazolidinediones | 2004 |